CNO Q2 Earnings Beat Estimates on Strong Annuity Collected Premiums

CNO Financial Group reported mixed Q2 2025 results, with adjusted EPS of $0.87 surpassing consensus but declining 17% year-over-year, while operating revenues of $1.2 billion rose 8% and exceeded expectations. The company saw strong performance in annuity collected premiums, which surged 19% to $520.5 million, and growth in new annualized health and life premiums. However, higher insurance policy benefits and operating costs drove total expenses up 12.9%, and net investment losses continued to pressure margins, contributing to a 2% decline in CNO shares post-announcement. CNO reaffirmed its 2025 operating EPS guidance of $3.70-$3.90, signaling a consistent outlook despite current cost pressures.

Analysis

CNO Financial Group reported mixed second-quarter 2025 results, characterized by strong top-line growth offset by significant margin pressure. Operating revenues grew 8% year-over-year to $1.2 billion, handily beating consensus estimates by 19.3%, driven primarily by a 19% surge in annuity collected premiums to $520.5 million. This underlying business momentum was further evidenced by robust growth in new annualized premiums for life (+22.2%) and health (+10.7%) products. However, these gains were overshadowed by a 17% year-over-year decline in adjusted EPS to 87 cents, a direct result of total expenses escalating 12.9% due to higher insurance policy benefits and operating costs. The company's balance sheet presents a similarly conflicting picture: while unrestricted cash plunged 53.8% from the end of 2024, the debt-to-capital ratio improved by 760 basis points to 34.6% and book value per common share increased 4.7%. Despite the profitability headwinds and a 2% post-earnings share price decline, management reaffirmed its full-year EPS guidance of $3.70-$3.90 and narrowed its expense ratio forecast, signaling confidence in its ability to manage costs moving forward while continuing shareholder returns via a $100 million buyback.

Key Decisions for Investors

• Investors should weigh the robust underlying business growth, evidenced by a 19% increase in annuity premiums and strong new business generation, against the significant 17% year-over-year decline in earnings per share driven by escalating costs.
• Monitor the company's progress toward its improved expense ratio guidance of 19-19.2% in subsequent quarters, as success in cost containment is critical to restoring bottom-line growth and investor confidence.
• The sharp 53.8% reduction in unrestricted cash from year-end is a key risk factor to watch, though this is partly mitigated by an aggressive share repurchase program and an improving debt-to-capital ratio.
• Given the conflicting signals of strong revenue and weak profitability, a neutral stance may be warranted until there is clear evidence that top-line strength can be translated into margin expansion and sustained earnings growth.